Table 1.

Association among Gleason scores, PSA levels, periostin, integrin-α4, fibronectin expressions in the mCRPC patient group

	Periostin				Integrin-α4			Fibronectin
	n	Mean	Median	P	Mean	Median	P	Mean	Median	P
Gleason score
8	12	5.8 ± 2.75	5.4 (2–9.9)	0.329	1.6 ± 2.81	0.15 (0.03–7.6)	0.795	8.1 ± 3.28	8.5 (0.01–12.5)	0.321
9	16	4.3 ± 2.57	3.6 (0.9–9.1)		1.4 ± 1.43	0.6 (0.02–4.1)		5.5 ± 4.19	5.2 (0.09–14.1)
10	12	4.9 ± 2.58	5 (2–10.8)		1.5 ± 1.97	0.3 (0.02–5.5)		6.6 ± 3.82	7.4 (0.04–11.4)
PSA (ng/ml)
<20	9	4.2 ± 2.00	3.8 (0.9–6.5)	0.486	1.3 ± 2.37	0.1 (0.03–7.4)	0.446	5.7 ± 3.76	5.8 (0.8–10.2)	0.549
≥20	31	5.2 ± 2.78	4.5 (1.6–10.9)		1.5 ± 1.96	0.5 (0.01–7.6)		6.9 ± 3.93	7.3 (0.01–14.1)

PSA: prostate-specific antigen; mCRPC: metastatic castration-resistant prostate cancer.